Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Rigel Pharmaceuticals (RIGL)

Rigel Pharmaceuticals (RIGL)
15.00 x 2 19.25 x 4
Post-market by (Cboe BZX)
17.74 +0.81 (+4.78%) 04/22/25 [NASDAQ]
15.00 x 2 19.25 x 4
Post-market 17.74 unch (unch) 16:01 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
16.90
Day High
17.82
Open 17.16
Previous Close 16.93 16.93
Volume 133,800 133,800
Avg Vol 224,065 224,065
Stochastic %K 58.94% 58.94%
Weighted Alpha +15.29 +15.29
5-Day Change +0.53 (+3.08%) +0.53 (+3.08%)
52-Week Range 7.48 - 29.82 7.48 - 29.82
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 302,488
  • Shares Outstanding, K 17,867
  • Annual Sales, $ 179,280 K
  • Annual Income, $ 17,490 K
  • EBIT $ 24 M
  • EBITDA $ 26 M
  • 60-Month Beta 1.32
  • Price/Sales 1.68
  • Price/Cash Flow 15.62
  • Price/Book 90.27

Options Overview Details

View History
  • Implied Volatility 105.73% ( +23.61%)
  • Historical Volatility 54.84%
  • IV Percentile 76%
  • IV Rank 60.84%
  • IV High 169.02% on 05/03/24
  • IV Low 7.41% on 10/11/24
  • Put/Call Vol Ratio 0.45
  • Today's Volume 16
  • Volume Avg (30-Day) 39
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 913
  • Open Int (30-Day) 913

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.14
  • Number of Estimates 4
  • High Estimate 0.37
  • Low Estimate -0.07
  • Prior Year -0.50
  • Growth Rate Est. (year over year) +128.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.50 +14.45%
on 04/09/25
Period Open: 20.20
20.72 -14.38%
on 03/24/25
-2.46 (-12.18%)
since 03/21/25
3-Month
15.50 +14.45%
on 04/09/25
Period Open: 21.81
24.48 -27.54%
on 02/06/25
-4.07 (-18.66%)
since 01/22/25
52-Week
7.48 +137.03%
on 07/05/24
Period Open: 11.30
29.82 -40.51%
on 11/12/24
+6.44 (+56.99%)
since 04/22/24

Most Recent Stories

More News
4 Healthcare Stocks to Buy as the Sector Faces Government Heat

The U.S. healthcare sector is currently navigating a complex landscape characterized by technological innovation, policy shifts, financial pressures and evolving consumer expectations. While artificial...

FOLD : 6.91 (+2.98%)
RIGL : 17.74 (+4.78%)
ENSG : 122.06 (+1.78%)
BVS : 7.49 (-0.13%)
AXSM Settles Sunosi Patent Litigation With Hikma Pharmaceuticals

Axsome Therapeutics AXSM announced that it has entered into a settlement agreement with Hikma Pharmaceuticals related to patents for its narcolepsy drug, Sunosi (solriamfetol).The settlement agreement...

JAZZ : 103.38 (+3.03%)
RIGL : 17.74 (+4.78%)
ANIP : 68.95 (+1.40%)
AXSM : 103.82 (+0.80%)
ESPR's Q4 Loss Narrower Than Expected, Revenues Increase Y/Y

Esperion Therapeutics ESPR incurred a fourth-quarter 2024 loss of 10 cents per share (excluding one-time expenses of loss on extinguishment of debt and exchange transaction), which was narrower than the...

ESPR : 0.9297 (+9.12%)
RIGL : 17.74 (+4.78%)
PCRX : 25.45 (-1.74%)
Rigel: Q4 Earnings Snapshot

Rigel: Q4 Earnings Snapshot

RIGL : 17.74 (+4.78%)
Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Drug Buzz

The intense retail focus on Anavex reflects a broader market interest in neurodegenerative therapies, especially following disappointing trial results from Cassava Sciences’ simufilam.

AVXL : 9.21 (+5.14%)
RIGL : 17.74 (+4.78%)
NVAX : 6.25 (+3.99%)
Small-Cap Stocks Can Outperform Large-Cap Peers in 2025: 5 Top Picks

U.S. stock markets witnessed an impressive rally in 2024 after an astonishing bull run in 2023. Following the 24.2% ascent in 2023, the S&P 500 rallied 23.3% last year. The Dow and the Nasdaq Composite...

LIND : 8.31 (+2.85%)
TZOO : 12.45 (-0.40%)
RIGL : 17.74 (+4.78%)
GHM : 29.62 (+3.13%)
EVER : 22.59 (+6.16%)
Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term

Genomics companies analyze and interpret genetic information to uncover insights about genetic variations and disease mechanisms and develop tests, therapies and technologies to advance personalized medicine. Companies...

IMCR : 29.52 (+0.37%)
CRSP : 39.23 (+3.73%)
GLUE : 4.81 (+7.85%)
CSTL : 21.98 (+3.97%)
RIGL : 17.74 (+4.78%)
3 Ways to Invest in Small-Cap Stocks Now

With small-cap stocks surging in response to Donald Trump's re-election and the Federal Reserve's rate cut, investors can tap into this momentum through three distinct ETFs: VBK, DWAS, and UWM, each offering...

TRGP : 170.90 (+3.87%)
LMB : 87.47 (+6.48%)
MOD : 72.20 (+4.18%)
DRS : 35.14 (+1.53%)
DWAS : 73.81 (+2.87%)
AXON : 555.52 (+2.51%)
UWM : 28.81 (+5.42%)
LII : 558.93 (+3.31%)
DECK : 106.42 (+2.77%)
RIGL : 17.74 (+4.78%)
STRL : 133.92 (+1.79%)
VBK : 236.09 (+2.50%)
Rigel: Q3 Earnings Snapshot

Rigel: Q3 Earnings Snapshot

RIGL : 17.74 (+4.78%)
Rigel: Q2 Earnings Snapshot

Rigel: Q2 Earnings Snapshot

RIGL : 17.74 (+4.78%)

Business Summary

Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its goal is to file one new investigative new drug application in a significant indication each year....

See More

Key Turning Points

3rd Resistance Point 18.99
2nd Resistance Point 18.41
1st Resistance Point 18.07
Last Price 17.74
1st Support Level 17.15
2nd Support Level 16.57
3rd Support Level 16.23

See More

52-Week High 29.82
Fibonacci 61.8% 21.29
Fibonacci 50% 18.65
Last Price 17.74
Fibonacci 38.2% 16.02
52-Week Low 7.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro